 Vijayalakshmi Karoor
Concepts (263)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neprilysin | 4 | 2017 | 47 | 1.190 |
Why?
| | rho GTP-Binding Proteins | 2 | 2020 | 56 | 1.110 |
Why?
| | Muscle, Smooth, Vascular | 6 | 2017 | 444 | 1.000 |
Why?
| | Hypoxia | 8 | 2023 | 1199 | 0.830 |
Why?
| | Pulmonary Artery | 13 | 2020 | 1127 | 0.810 |
Why?
| | Hypertension, Pulmonary | 11 | 2021 | 1957 | 0.800 |
Why?
| | rhoA GTP-Binding Protein | 4 | 2019 | 76 | 0.760 |
Why?
| | rho-Associated Kinases | 5 | 2019 | 82 | 0.760 |
Why?
| | Vascular Remodeling | 3 | 2021 | 209 | 0.750 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 2 | 2012 | 86 | 0.670 |
Why?
| | Butyrates | 1 | 2021 | 66 | 0.650 |
Why?
| | Metabolic Diseases | 1 | 2021 | 114 | 0.640 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2021 | 231 | 0.600 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 266 | 0.590 |
Why?
| | Cellular Microenvironment | 1 | 2019 | 93 | 0.570 |
Why?
| | Metabolome | 1 | 2021 | 387 | 0.540 |
Why?
| | Pneumonia | 2 | 2021 | 632 | 0.500 |
Why?
| | Vascular Diseases | 1 | 2019 | 252 | 0.480 |
Why?
| | Myocardium | 3 | 2019 | 932 | 0.480 |
Why?
| | Muscle Proteins | 1 | 2017 | 242 | 0.470 |
Why?
| | Endothelial Cells | 6 | 2023 | 866 | 0.450 |
Why?
| | Quinazolines | 3 | 2012 | 266 | 0.430 |
Why?
| | Vasa Vasorum | 3 | 2020 | 36 | 0.430 |
Why?
| | Carcinogens | 2 | 2012 | 123 | 0.420 |
Why?
| | Lung | 6 | 2021 | 4103 | 0.400 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 951 | 0.380 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 31 | 0.380 |
Why?
| | Cardiovascular Diseases | 2 | 2021 | 2185 | 0.360 |
Why?
| | Piperidines | 2 | 2012 | 221 | 0.360 |
Why?
| | Animals | 30 | 2023 | 38141 | 0.350 |
Why?
| | Neovascularization, Pathologic | 4 | 2020 | 284 | 0.330 |
Why?
| | Pulmonary Alveoli | 2 | 2012 | 383 | 0.310 |
Why?
| | ErbB Receptors | 2 | 2012 | 635 | 0.300 |
Why?
| | Lung Neoplasms | 3 | 2012 | 2664 | 0.290 |
Why?
| | Aging | 1 | 2020 | 1940 | 0.290 |
Why?
| | Signal Transduction | 9 | 2020 | 5202 | 0.270 |
Why?
| | Hemoglobins | 3 | 2021 | 386 | 0.260 |
Why?
| | Anemia, Sickle Cell | 2 | 2021 | 318 | 0.240 |
Why?
| | Heart Failure | 1 | 2019 | 2329 | 0.230 |
Why?
| | Proto-Oncogene Proteins c-myc | 2 | 2020 | 167 | 0.220 |
Why?
| | Mice, Knockout | 6 | 2023 | 3125 | 0.210 |
Why?
| | Propranolol | 1 | 2004 | 44 | 0.200 |
Why?
| | Enzyme Activation | 5 | 2017 | 762 | 0.200 |
Why?
| | Receptors, Purinergic P2Y | 2 | 2020 | 9 | 0.200 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2020 | 125 | 0.200 |
Why?
| | Rats | 10 | 2021 | 5581 | 0.190 |
Why?
| | Up-Regulation | 2 | 2021 | 848 | 0.190 |
Why?
| | Macrophages | 2 | 2021 | 1509 | 0.180 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2004 | 252 | 0.180 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2021 | 149 | 0.180 |
Why?
| | Endothelin-1 | 2 | 2017 | 181 | 0.180 |
Why?
| | Urethane | 2 | 2012 | 43 | 0.170 |
Why?
| | Sleep Apnea Syndromes | 2 | 2013 | 98 | 0.170 |
Why?
| | Mice | 12 | 2023 | 18338 | 0.170 |
Why?
| | Systole | 1 | 2021 | 181 | 0.170 |
Why?
| | Rats, Sprague-Dawley | 5 | 2021 | 2526 | 0.170 |
Why?
| | Tight Junctions | 1 | 2021 | 82 | 0.170 |
Why?
| | Hemopexin | 1 | 2021 | 38 | 0.170 |
Why?
| | Acetylation | 1 | 2021 | 250 | 0.160 |
Why?
| | Cytokines | 3 | 2021 | 2054 | 0.160 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2020 | 153 | 0.160 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2023 | 407 | 0.160 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2020 | 20 | 0.160 |
Why?
| | Microvessels | 1 | 2021 | 98 | 0.160 |
Why?
| | Forkhead Box Protein O3 | 1 | 2020 | 18 | 0.160 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2020 | 56 | 0.160 |
Why?
| | Endothelium | 1 | 2020 | 119 | 0.150 |
Why?
| | Blood Pressure | 4 | 2021 | 1782 | 0.150 |
Why?
| | Ligands | 1 | 2021 | 667 | 0.150 |
Why?
| | Cell Proliferation | 3 | 2017 | 2499 | 0.150 |
Why?
| | GTPase-Activating Proteins | 1 | 2019 | 81 | 0.140 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2019 | 63 | 0.140 |
Why?
| | Pulmonary Circulation | 3 | 2009 | 430 | 0.140 |
Why?
| | Adenosine | 1 | 2020 | 256 | 0.140 |
Why?
| | Cell Movement | 2 | 2017 | 961 | 0.140 |
Why?
| | Immune System | 1 | 2019 | 178 | 0.140 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2017 | 11 | 0.130 |
Why?
| | Smooth Muscle Myosins | 1 | 2017 | 7 | 0.130 |
Why?
| | Leukocytes | 1 | 2019 | 295 | 0.130 |
Why?
| | Mice, Inbred C57BL | 5 | 2017 | 5989 | 0.130 |
Why?
| | Disease Susceptibility | 1 | 2019 | 343 | 0.130 |
Why?
| | Xanthine Dehydrogenase | 1 | 2017 | 24 | 0.130 |
Why?
| | Dehydroepiandrosterone | 2 | 2008 | 49 | 0.130 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2017 | 79 | 0.130 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 426 | 0.130 |
Why?
| | Phenotype | 2 | 2017 | 3157 | 0.130 |
Why?
| | Microfilament Proteins | 1 | 2017 | 136 | 0.120 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 37 | 0.120 |
Why?
| | Cigarette Smoking | 1 | 2018 | 101 | 0.120 |
Why?
| | Heart Ventricles | 1 | 2021 | 754 | 0.120 |
Why?
| | Calcium-Binding Proteins | 1 | 2017 | 222 | 0.120 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2018 | 108 | 0.120 |
Why?
| | Reactive Oxygen Species | 1 | 2019 | 602 | 0.120 |
Why?
| | Cells, Cultured | 3 | 2017 | 4127 | 0.110 |
Why?
| | Oxidative Phosphorylation | 1 | 2016 | 209 | 0.110 |
Why?
| | Actins | 1 | 2017 | 421 | 0.110 |
Why?
| | Nicotine | 1 | 2018 | 334 | 0.110 |
Why?
| | Neovascularization, Physiologic | 1 | 2016 | 191 | 0.110 |
Why?
| | Inflammation | 2 | 2023 | 2883 | 0.110 |
Why?
| | Myocytes, Cardiac | 1 | 2019 | 544 | 0.110 |
Why?
| | Glycolysis | 1 | 2016 | 342 | 0.110 |
Why?
| | Humans | 13 | 2021 | 145491 | 0.110 |
Why?
| | Genotype | 2 | 2017 | 1853 | 0.100 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1058 | 0.100 |
Why?
| | Models, Biological | 1 | 2021 | 1815 | 0.100 |
Why?
| | Blotting, Western | 3 | 2012 | 1162 | 0.100 |
Why?
| | Fibroblasts | 1 | 2019 | 1023 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 2 | 2010 | 980 | 0.100 |
Why?
| | Methylcholanthrene | 1 | 2012 | 21 | 0.090 |
Why?
| | Butylated Hydroxytoluene | 1 | 2012 | 37 | 0.090 |
Why?
| | Immunoenzyme Techniques | 1 | 2012 | 199 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2004 | 287 | 0.090 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2002 | 123 | 0.080 |
Why?
| | Mice, Transgenic | 3 | 2023 | 2189 | 0.080 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2012 | 211 | 0.080 |
Why?
| | Alcoholism | 1 | 2017 | 821 | 0.080 |
Why?
| | In Vitro Techniques | 3 | 2007 | 1047 | 0.080 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 919 | 0.080 |
Why?
| | Chemoprevention | 1 | 2010 | 92 | 0.080 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2010 | 65 | 0.080 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2010 | 161 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2010 | 2030 | 0.070 |
Why?
| | Antioxidants | 1 | 2012 | 549 | 0.070 |
Why?
| | Monocrotaline | 1 | 2008 | 31 | 0.070 |
Why?
| | Biomarkers | 1 | 2020 | 4283 | 0.070 |
Why?
| | Molecular Targeted Therapy | 1 | 2010 | 439 | 0.060 |
Why?
| | Guanylate Cyclase | 1 | 2007 | 38 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2019 | 4559 | 0.060 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 246 | 0.060 |
Why?
| | Cattle | 2 | 2020 | 977 | 0.060 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2005 | 456 | 0.060 |
Why?
| | Calcineurin | 2 | 2003 | 105 | 0.060 |
Why?
| | Serotonin | 1 | 2007 | 295 | 0.060 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 207 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2012 | 1321 | 0.050 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2004 | 8 | 0.050 |
Why?
| | Arrestins | 1 | 2004 | 14 | 0.050 |
Why?
| | Angiotensin II | 1 | 2004 | 98 | 0.050 |
Why?
| | Heat Shock Transcription Factors | 1 | 2023 | 21 | 0.050 |
Why?
| | Aortic Stenosis, Subvalvular | 1 | 2003 | 4 | 0.050 |
Why?
| | Adenocarcinoma | 1 | 2010 | 923 | 0.050 |
Why?
| | Autonomic Nervous System | 1 | 2003 | 82 | 0.050 |
Why?
| | Heat-Shock Response | 1 | 2023 | 77 | 0.050 |
Why?
| | Antibodies, Monoclonal | 1 | 2010 | 1511 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 265 | 0.050 |
Why?
| | Phosphorylation | 2 | 2004 | 1707 | 0.050 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2023 | 196 | 0.050 |
Why?
| | MAP Kinase Kinase Kinase 1 | 1 | 2002 | 18 | 0.050 |
Why?
| | Forkhead Transcription Factors | 1 | 2023 | 207 | 0.050 |
Why?
| | Oxidative Stress | 2 | 2020 | 1350 | 0.040 |
Why?
| | Myocardial Contraction | 1 | 2003 | 291 | 0.040 |
Why?
| | Male | 12 | 2020 | 72817 | 0.040 |
Why?
| | Enzyme Inhibitors | 2 | 2005 | 821 | 0.040 |
Why?
| | Antineoplastic Agents | 2 | 2010 | 2207 | 0.040 |
Why?
| | Protein Kinases | 1 | 2004 | 314 | 0.040 |
Why?
| | Calcineurin Inhibitors | 1 | 2001 | 69 | 0.040 |
Why?
| | Heme | 1 | 2021 | 89 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2023 | 550 | 0.040 |
Why?
| | Cyclosporine | 1 | 2001 | 256 | 0.040 |
Why?
| | Extracellular Fluid | 1 | 2020 | 38 | 0.040 |
Why?
| | Hemolysis | 1 | 2021 | 242 | 0.040 |
Why?
| | Gadolinium | 1 | 2019 | 84 | 0.040 |
Why?
| | Female | 5 | 2017 | 78763 | 0.040 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2020 | 380 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2020 | 436 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2017 | 88 | 0.030 |
Why?
| | Injections | 1 | 2018 | 200 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2020 | 503 | 0.030 |
Why?
| | Neoplasms | 1 | 2013 | 2897 | 0.030 |
Why?
| | Anemia, Hemolytic | 1 | 2017 | 21 | 0.030 |
Why?
| | Receptors, Purinergic | 1 | 2016 | 20 | 0.030 |
Why?
| | Cyclooxygenase 2 | 1 | 2017 | 166 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2017 | 163 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2020 | 452 | 0.030 |
Why?
| | Apoptosis | 2 | 2002 | 2411 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 168 | 0.030 |
Why?
| | Vasoconstriction | 2 | 2007 | 216 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2017 | 390 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 855 | 0.030 |
Why?
| | Atrial Natriuretic Factor | 2 | 2003 | 55 | 0.020 |
Why?
| | Chronic Disease | 2 | 2009 | 1816 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2017 | 772 | 0.020 |
Why?
| | Hemodynamics | 2 | 2009 | 1116 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2862 | 0.020 |
Why?
| | Rats, Inbred WKY | 1 | 2009 | 35 | 0.020 |
Why?
| | Receptors, Chemokine | 1 | 2009 | 48 | 0.020 |
Why?
| | Dinoprostone | 1 | 2010 | 180 | 0.020 |
Why?
| | Epoprostenol | 1 | 2010 | 132 | 0.020 |
Why?
| | Cadherins | 1 | 2010 | 200 | 0.020 |
Why?
| | Chemokines | 1 | 2009 | 218 | 0.020 |
Why?
| | Gene Expression Regulation | 2 | 2009 | 2594 | 0.020 |
Why?
| | Cell Adhesion Molecules | 1 | 2009 | 181 | 0.020 |
Why?
| | Endothelin B Receptor Antagonists | 1 | 2007 | 12 | 0.020 |
Why?
| | Endothelin A Receptor Antagonists | 1 | 2007 | 24 | 0.020 |
Why?
| | DNA Primers | 1 | 2009 | 507 | 0.020 |
Why?
| | Potassium Chloride | 1 | 2007 | 40 | 0.020 |
Why?
| | Adenoma | 1 | 2010 | 218 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 376 | 0.020 |
Why?
| | Cell Division | 1 | 2009 | 753 | 0.020 |
Why?
| | Soluble Guanylyl Cyclase | 1 | 2007 | 15 | 0.020 |
Why?
| | Amides | 1 | 2007 | 99 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2009 | 751 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 268 | 0.020 |
Why?
| | Nitroprusside | 1 | 2007 | 71 | 0.020 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 2007 | 42 | 0.020 |
Why?
| | Cyclic GMP | 1 | 2007 | 90 | 0.020 |
Why?
| | Aorta, Thoracic | 1 | 2009 | 286 | 0.020 |
Why?
| | Perfusion | 1 | 2007 | 249 | 0.010 |
Why?
| | Pneumonectomy | 1 | 2008 | 167 | 0.010 |
Why?
| | Monocytes | 1 | 2009 | 536 | 0.010 |
Why?
| | Acetylcholine | 1 | 2007 | 208 | 0.010 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2007 | 203 | 0.010 |
Why?
| | Random Allocation | 1 | 2007 | 366 | 0.010 |
Why?
| | Peptides, Cyclic | 1 | 2007 | 275 | 0.010 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2005 | 28 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 2005 | 320 | 0.010 |
Why?
| | Dendritic Cells | 1 | 2009 | 499 | 0.010 |
Why?
| | Vasodilator Agents | 1 | 2007 | 330 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 782 | 0.010 |
Why?
| | beta-Arrestin 1 | 1 | 2004 | 4 | 0.010 |
Why?
| | beta-Arrestin 2 | 1 | 2004 | 8 | 0.010 |
Why?
| | beta-Arrestins | 1 | 2004 | 15 | 0.010 |
Why?
| | Clathrin | 1 | 2004 | 26 | 0.010 |
Why?
| | Genes, Dominant | 1 | 2004 | 100 | 0.010 |
Why?
| | CHO Cells | 1 | 2004 | 166 | 0.010 |
Why?
| | COS Cells | 1 | 2004 | 177 | 0.010 |
Why?
| | Cricetinae | 1 | 2004 | 299 | 0.010 |
Why?
| | Time Factors | 2 | 2008 | 7171 | 0.010 |
Why?
| | Autonomic Denervation | 1 | 2003 | 2 | 0.010 |
Why?
| | Endocytosis | 1 | 2004 | 168 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2004 | 318 | 0.010 |
Why?
| | Aorta, Abdominal | 1 | 2003 | 52 | 0.010 |
Why?
| | Estradiol | 1 | 2007 | 507 | 0.010 |
Why?
| | Pyridines | 1 | 2007 | 607 | 0.010 |
Why?
| | Electrophysiology | 1 | 2003 | 218 | 0.010 |
Why?
| | Immunoblotting | 1 | 2003 | 294 | 0.010 |
Why?
| | Testosterone | 1 | 2007 | 413 | 0.010 |
Why?
| | Protein Transport | 1 | 2004 | 438 | 0.010 |
Why?
| | Green Fluorescent Proteins | 1 | 2004 | 407 | 0.010 |
Why?
| | Potassium Channels | 1 | 2003 | 147 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2004 | 850 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2007 | 894 | 0.010 |
Why?
| | Models, Animal | 1 | 2003 | 395 | 0.010 |
Why?
| | Calcium Signaling | 1 | 2003 | 244 | 0.010 |
Why?
| | Ligation | 1 | 2001 | 91 | 0.010 |
Why?
| | Cell Size | 1 | 2001 | 92 | 0.010 |
Why?
| | Altitude | 1 | 2005 | 473 | 0.010 |
Why?
| | Injections, Subcutaneous | 1 | 2001 | 170 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 2001 | 396 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2004 | 2137 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2355 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 2910 | 0.010 |
Why?
| | Calcium | 1 | 2005 | 1190 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 2002 | 475 | 0.010 |
Why?
| | Fibrosis | 1 | 2001 | 551 | 0.010 |
Why?
| | Iron | 1 | 2001 | 359 | 0.010 |
Why?
| | Aorta | 1 | 2001 | 439 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2002 | 1212 | 0.010 |
Why?
| | Gene Expression | 1 | 2002 | 1478 | 0.010 |
Why?
| | Kidney | 1 | 2004 | 1498 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2003 | 2820 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 36176 | 0.010 |
Why?
| | Adult | 1 | 2017 | 40707 | 0.010 |
Why?
|
|
Karoor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|